A detailed history of Great West Life Assurance CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 49,122 shares of AMPH stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,122
Previous 39,930 23.02%
Holding current value
$2.37 Million
Previous $1.75 Million 12.16%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$38.65 - $43.48 $355,270 - $399,668
9,192 Added 23.02%
49,122 $1.97 Million
Q1 2024

May 13, 2024

BUY
$42.85 - $63.45 $387,235 - $573,397
9,037 Added 29.25%
39,930 $1.75 Million
Q4 2023

Feb 13, 2024

SELL
$44.49 - $62.93 $107,843 - $152,542
-2,424 Reduced 7.28%
30,893 $1.91 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $35,497 - $50,700
780 Added 2.4%
33,317 $1.53 Million
Q2 2023

Aug 10, 2023

SELL
$35.77 - $58.38 $105,628 - $172,396
-2,953 Reduced 8.32%
32,537 $1.87 Million
Q1 2023

May 12, 2023

SELL
$27.99 - $37.92 $69,275 - $93,852
-2,475 Reduced 6.52%
35,490 $1.33 Million
Q4 2022

Feb 10, 2023

SELL
$27.93 - $31.27 $122,947 - $137,650
-4,402 Reduced 10.39%
37,965 $1.06 Million
Q3 2022

Nov 01, 2022

BUY
$27.56 - $37.75 $1.17 Million - $1.6 Million
42,367 New
42,367 $1.19 Million
Q2 2022

Aug 09, 2022

BUY
$29.79 - $42.29 $155,980 - $221,430
5,236 Added 16.22%
37,512 $1.3 Million
Q1 2022

May 12, 2022

SELL
$22.96 - $36.45 $4,936 - $7,836
-215 Reduced 0.66%
32,276 $1.19 Million
Q4 2021

Feb 14, 2022

SELL
$18.14 - $23.29 $3,682 - $4,727
-203 Reduced 0.62%
32,491 $756,000
Q3 2021

Nov 15, 2021

BUY
$17.83 - $21.49 $40,010 - $48,223
2,244 Added 7.37%
32,694 $627,000
Q1 2021

May 17, 2021

SELL
$17.21 - $20.65 $83,348 - $100,007
-4,843 Reduced 13.72%
30,450 $557,000
Q4 2020

Feb 16, 2021

SELL
$17.76 - $21.24 $92,636 - $110,787
-5,216 Reduced 12.88%
35,293 $710,000
Q3 2020

Nov 17, 2020

SELL
$17.99 - $22.22 $597,807 - $738,370
-33,230 Reduced 45.06%
40,509 $759,000
Q3 2020

Nov 13, 2020

BUY
$17.99 - $22.22 $582,983 - $720,061
32,406 Added 78.4%
73,739 $1.38 Million
Q2 2020

Aug 17, 2020

SELL
$14.25 - $22.46 $32,162 - $50,692
-2,257 Reduced 5.18%
41,333 $927,000
Q1 2020

May 14, 2020

BUY
$12.66 - $20.08 $6,393 - $10,140
505 Added 1.17%
43,590 $642,000
Q4 2019

Feb 11, 2020

BUY
$17.07 - $20.64 $735,460 - $889,274
43,085 New
43,085 $831,000
Q3 2019

Oct 25, 2019

SELL
$19.12 - $22.62 $888,372 - $1.05 Million
-46,463 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$19.46 - $25.28 $50,596 - $65,728
2,600 Added 5.93%
46,463 $949,000
Q1 2018

May 10, 2018

SELL
$17.23 - $20.35 $42,627 - $50,345
-2,474 Reduced 5.34%
43,863 $822,000
Q3 2017

Nov 09, 2017

BUY
$14.73 - $17.99 $682,544 - $833,602
46,337
46,337 $828,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.37B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.